Scarica l'app Stockscreener
0.8151
0.32%
-0.0026
Pre-mercato:
.80
-0.0151
-1.85%
Precedente Chiudi:
$0.8177
Aprire:
$0.8051
Volume 24 ore:
43,478
Relative Volume:
0.23
Capitalizzazione di mercato:
$42.30M
Reddito:
$28,000
Utile/perdita netta:
$-14.36M
Rapporto P/E:
-2.2455
EPS:
-0.363
Flusso di cassa netto:
$-11.36M
1 W Prestazione:
-3.88%
1M Prestazione:
+3.69%
6M Prestazione:
-39.17%
1 anno Prestazione:
+61.73%
Intervallo 1D:
$0.8051
$0.8476
Intervallo di 1 settimana:
$0.77
$0.879
Portata 52W:
$0.38
$1.57
Talphera Inc Stock (TLPH) Company Profile
Nome
Talphera Inc
Settore
Telefono
650-216-3500
Indirizzo
1850 GATEWAY DRIVE, SAN MATEO
Compare TLPH vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLPH
Talphera Inc
|
0.8151 | 42.44M | 28,000 | -14.36M | -11.36M | -0.363 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2020-07-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2019-11-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-08-05 | Ripresa | Credit Suisse | Outperform |
| 2019-07-10 | Ripresa | Credit Suisse | Outperform |
| 2019-04-24 | Ripresa | B. Riley FBR | Buy |
| 2019-02-15 | Iniziato | Credit Suisse | Outperform |
| 2018-10-23 | Iniziato | B. Riley FBR | Buy |
| 2017-10-13 | Downgrade | Jefferies | Buy → Hold |
| 2017-10-13 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-07-14 | Ripresa | Jefferies | Buy |
| 2016-09-15 | Reiterato | ROTH Capital | Buy |
| 2016-08-05 | Downgrade | Stifel | Buy → Hold |
| 2015-10-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2015-10-05 | Reiterato | ROTH Capital | Buy |
| 2015-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2015-07-10 | Ripresa | ROTH Capital | Buy |
| 2015-05-06 | Reiterato | Mizuho | Neutral |
| 2015-05-05 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-03-10 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-03-09 | Downgrade | Mizuho | Buy → Neutral |
Mostra tutto
Talphera Inc Borsa (TLPH) Ultime notizie
Talphera Inc. (TLPH) Edges Higher as Shares Test Key Resistance at $0.88Bollinger Expansion - Newser
TALPHERA (TLPH) CMO surrenders 4,518 shares to cover RSU tax - Stock Titan
Talphera Earnings Call Highlights NEPHRO Trial Momentum - The Globe and Mail
TLPH Stock Price, Quote & Chart | TALPHERA INC (NASDAQ:TLPH) - ChartMill
WestPark Capital initiates coverage of Talphera (TLPH) with buy recommendation - MSN
Talphera (TLPH) Amendment: Lytton reports 1.25M shares, 2.5% - Stock Titan
Maxim Group Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Talphera Earnings Call Highlights Trial Momentum, Risks - TipRanks
A. G. P. Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3.5 - Moomoo
Talphera, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEF - GuruFocus
How to Value Talphera (TLPH) After Q1 2026 Earnings? EPS: Not Di - GuruFocus
Talphera (TLPH) Q1 2026 Earnings Transcript - AOL.com
TLPHNafamostat Study Enrollment Progress and Financial Update - GuruFocus
Talphera targets Niyad PMA filing in 2026 and potential approval in 2027 as NEPHRO enrollment surpasses 50% - MSN
Talphera, Inc Q1 Net Income From Continuing Operations USD -2.556 Million - TradingView
Talphera Q1 2026 Earnings Call Transcript - Benzinga
TLPH: NEPHRO study enrollment exceeds 50%, with top-line data expected in H2 2026 - TradingView
Earnings call transcript: Talphera Inc Q1 2026 highlights cash position and clinical progress - Investing.com UK
Talphera (NASDAQ: TLPH) posts Q1 2026 loss and flags going concern, Nasdaq risk - Stock Titan
Talphera, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Talphera: Q1 Earnings Snapshot - kare11.com
MSN Money - MSN
Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEFRO Study Progress Amid Rising ... By GuruFocus - Investing.com Canada
Rosalind-backed holders report 12.9M shares in Talphera (NASDAQ: TLPH) - Stock Titan
Number of shareholders of Talphera, Inc. – NASDAQ:TLPH - TradingView
Talphera Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Is Talphera (TLPH) stock hiding in plain sight? (Smart Money Active) 2026-05-08Reward Analysis - Newser
Talphera (TLPH.US) will release its earnings report after the market closes on May 13. - Moomoo
After the close, Talphera posts Q1 results and holds a 4:30 p.m. ET webcast - Stock Titan
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026 - ChartMill
How Talphera (TLPH) revenue breaks down and what it means (Edges Higher) 2026-05-07Stock News - newser.com
TLPH Stock: WestPark Capital Initiates Buy Rating, May 2026 - Meyka
TLPH Initiated Coverage by WestPark Capital -- Rating Set to Buy - GuruFocus
Talphera (NASDAQ: TLPH) seeks approval for equity and ESPP plan changes - Stock Titan
Talphera files prospectus for resale of up to 30.9M shares by selling stockholders - MSN
AcelRx Pharmaceuticals Q1 2025 Earnings Preview - MSN
Talphera Inc Azioni (TLPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Talphera Inc Azioni (TLPH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Feb 12 '26 |
Buy |
0.81 |
105,364 |
85,587 |
586,954 |
| Aslam Shakil | Chief Medical Officer |
Feb 12 '26 |
Buy |
0.81 |
35,000 |
28,430 |
83,178 |
| Dasu Badri N | Chief Engineering Officer |
Feb 12 '26 |
Buy |
0.81 |
35,000 |
28,430 |
76,230 |
| ASADORIAN RAFFI | Chief Financial Officer |
Feb 12 '26 |
Buy |
0.81 |
45,000 |
36,554 |
91,256 |
1.92%
4.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):